A hypothesis accounting for the inconsistent benefit of glucocorticoid therapy in closed head trauma

Medical Hypotheses

Volumn 56, Issue 1, 2001, Pages 65-72

  Borsody, M K ^a   Coco, M L ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Coco Communications Inc Atlanta ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; DEXAMETHASONE; FREE RADICAL; GLUCOCORTICOID; GLUTAMIC ACID; HYDROCORTISONE; KALLIKREIN; KININ; METHYLPREDNISOLONE; NITRIC OXIDE; OXYGEN RADICAL; TRIAMCINOLONE;

CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG INDICATION; HEAD INJURY; HUMAN; KALLIKREIN KININ SYSTEM; NEUROTOXICITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VASOSPASM;

EID: 0035170528     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2000.1113     Document Type: Article

References (95)

1. The use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery
2. Cortisone in the treatment of postoperative cerebral edema
3. Use of conticosteroids in neuro-oncology
4. Guidelines for the management of severe brain injury
5. The use of steroids for control of cerebral edema
6. Treatment of acute cerebral edema with a high dose of dexamethasone
7. The effects of steroids on brain edema in man
8. Steroids in severe head injury. A prospective randomized clinical trial
9. The influence of various doses of dexamethasone on intracranial pressure in patients with severe head injury
10. Prognostic features in recovery from traumatic decerebration
11. Decerebrate rigidity in acute head injury
12. Failure of high-dose steroid therapy to influence intracranial pressure in patients with severe head injury
13. Dexamethasone and severe head injury. A prospective double-blind study
14. Influence of the type of intracranial lesion on outcome from severe head injury
15. "Ultrahigh" dexamethasone in acute brain injury. Results from a prospective randomized double-blind multicenter trial (GUDHIS)
16. Treatment of patients with severe head injury by triamcinolone: A prospective, controlled multicenter clinical trial of 396 cases
17. Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity
18. Specificity of the adrenal steroid receptor system in rat hippocampus
19. Double-blind study on the effects of steroids on severe closed head injury
20. Nonsurgical management of severe head injuries
21. Effect of high-dose dexamethasone on outcome from severe head injury
22. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage
23. Dexamethasone as treatment in cerebrovascular disease. 1. A controlled study in intracerebral hemorrhage
24. Significance of intracranial hypertension in severe head injury
25. Characterization of cerebral hemodynamic phases following severe head trauma: Hypoperfusion, hyperemia, and vasospasm
26. Intracranial arterial narrowing and spasm in acute head injury
27. Prognostic significance of altered cerebrovascular blood flow velocity in acute head trauma
28. Cerebral arterial spasm after penetrating craniocerebral gunshot wounds: Transcranial Doppler and cerebral blood flow findings
29. Post-traumatic cerebral arterial spasm
30. Prognostic significance of cerebral arterial spasm in the course of meningeal haemorrhage
31. The relief of intracranial vasospasm: An experimental study with methylprednisolone and cortisol
32. Efficacy of steroid hormone in solution for intracranial irrigation during aneurysmal surgery for prevention of the vasospasm syndrome
33. Intravenous hydrocortisone in large doses in the treatment of delayed ischemic neurological deficits following subarachnoid hemorrhage - Results of a multicentered controlled double-blind clinical study
34. Microthrombi formation after severe head trauma
35. Intravascular coagulation: A common phenomenon in minor experimental head injury
36. Clinicopathological correlations of disseminated intravascular coagulation in patients with head injury
37. Coagulation disorders following acute head injury
38. Corticosteroids and the generalized Schwartzman reaction. Mechanisms of sensitization in the rabbit
39. Complement activation in the central nervous system following blood-brain barrier damage in man
40. Antibody-independent compliment activation by myelin via the classic complement pathway
41. Tissue culture demyelination by normal human serum
42. Activation of the endothelium by IL-1 alpha and glucocorticoids results in major increase of complement C3 and factor B production and generation of C3a
43. Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman factor)
44. Purified human plasma kallikrein aggregates human blood neutrophils
45. Purified human plasma kallikrein does not stimulate but primes neutrophils for superoxide production
46. The kallikrein-kinin system as mediator in vasogenic brain edema
47. Effects of bradykinin on permeability and diameter of pial vessels in vivo
48. Effects of bradykinin on blood-brain-barrier function and pial microcirculation
49. Regulation of renal kallikrein synthesis and activation by glucocorticoids
50. Glucocorticoid induction of angiotensin converting enzyme
51. Free radicals in CNS injury
52. Formation of malonaldehyde and focal brain edema induced by subpial injection of FeCl2 into rat isocortex
53. Concentrations of zinc, iron, molybdenum, arsenic, and lithium in cerebrospinal fluid of patients with brain tumors
54. Zinc concentrations in the cerebrospinal fluid of normal adults and patients with neurological diseases
55. The effect of the treatment of high-dose methylprednisolone on Na(+)-K(+)/Mg(+2) ATPase activity and lipid peroxidation and ultrastructural findings following cerebral contusion in rat
56. Nitric oxide synthase in motor neurons after axotomy
57. Cerebellar injury induces NADPH diaphorase in Purkinje and inferior olivary neurons in the rat
58. Effects of cerebral ischernia in mice deficient in neuronal nitric oxide synthase
59. Effect of nitric oxide on mitogenesis and proliferation of cerebellar glial cells
60. Nitric oxide mediates glutamate neurotoxicity in primary neuronal cultures
61. Effects of nitric oxide on hydrogen peroxide-induced damage in isolated rabbit gastric glands
62. Nitric oxide: A signal for ADP-ribosylation of proteins
63. Nitric oxide donor prevents hydrogen peroxide-mediated endothelial cell injury
64. Inhibition of nitric oxide formation in vivo enhances superoxide release by the perfused liver
65. Oxidation of nitrogen oxides by bound dioxygen in hemoproteins
66. Regulation of the expression of the inducible isoform of nitric oxide synthase by glucocorticoids
67. Applications of quantitative measurements for assessing glutamate neurotoxicity
68. Nerve cell death induced in vivo by kainic acid and quinolinic acid does not involve apoptosis
69. Metabotropic glutamate antagonist, MCPG, treatment of traumatic brain injury in rats
70. Glutamate metabotropic receptor agonist 1S.3R-ACPD induces internucleosomal DNA fragmentation and cell death in rat striatum
71. Excitatory amino acid receptor subtype binding following traumatic brain injury
72. Oxidative mechanisms involved in kainate-induced cytotoxicity in cortical neurons
73. Glutamate neurotoxicity is associated with nitric oxide-mediated mitrochondrial dysfunction and glutathione depletion
74. AMPA receptor-mediated excitotoxicity in human NT2-N neurons results from loss of intracellular Ca2+ homeostasis following marked elevation of intracellular Na+
75. The mixed lipoxygenase/cyclooxygenase inhibitor SK&F 105809 reduces cerebral edema after closed head injury in the rat
76. In vitro ischemia promotes glutamate-mediated free radical generation and intracellular calcium accumulation in hippocampal pyramidal neurons
77. Sequestration of glutamate-induced Ca2+ load by mitochondria in cultured rat hippocampal neurons
78. The role of excitatory amino acids and NMDA receptors in traumatic brain injury
79. Massive increase in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury
80. Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive injury in rats
81. Transient hippocampal hypermetabolism associated with glutamate release after acute subdural haematoma in the rat: A potentially neurotoxic mechanism?
82. Correlation of the extracellular glutamate concentration with extent of blood flow reduction after subdural haematoma in the rat
83. Changes in extracellular glutamate concentrations after acute subdural haematoma in the rat - Evidence for an "excitotoxic" mechanism?
84. Transient glucose hypermetabolism after acute subdural hematoma in the rat
85. Factors affecting excitatory amino acid release following severe human head injury
86. Hemoglobin potentiates excitotoxic injury in cortical cell culture
87. Neurotoxicity of hemoglobin in cortical cell culture
88. Serum prevents glutamate-induced mitochondrial calcium accumulation in primary neuronal cultures
89. Dexamethasone potentiates NMDA receptor-mediated neuronal injury in the postnatal rat
90. Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: Implications for glucocorticoid neurotoxicity
91. Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate
92. Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro
93. Influence of dexamethasone on neurotoxicity caused by oxygen and glucose deprivation in vitro
94. Hippocampal damage associated with prolonged glucocorticoid exposure in primates